Search

everythinglearnresearchcommunity

for

Search:↓

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Bath PUVA therapy works well for a skin condition without as many cancer risks and is cheaper, and iron deficiency might not cause female hair loss.

Combining laser therapy with platelet-rich plasma improves hair growth in people with hair loss.

No strong link between testosterone or DHEAS levels and acne or hair loss in females.

Finasteride may effectively treat hair loss in Klinefelter Syndrome patients.

Hair loss improved after removing pituitary tumor.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

Micro-needling with low-level light therapy effectively increases hair growth in people with mild to moderate hair loss.

Combining PRP with low-level laser therapy is better for hair growth than PRP alone.

Alopecia X causes hair loss in young plush-coated dogs and can be treated with various therapies, but hair may regrow and then fall out again.

PRP and LLLT can improve hair growth in AGA, but more research needed.

Female pattern hair loss, common in women, can be treated with various methods like minoxidil, anti-androgen treatments, and light therapy, but early intervention and realistic expectations are crucial.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Biotin deficiency is not a major cause of hair loss in women, so biotin supplements are not likely to be an effective hair loss treatment.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.